Joseph G. Pressey · Strategies for the Treatment of Infantile Soft Tissue Sarcomas With BCOR Alterations
Follow
Article1 min read·Published Jan 2023Older

Strategies for the Treatment of Infantile Soft Tissue Sarcomas With BCOR Alterations

pubmed.ncbi.nlm.nih.gov shows its articles on its own site.

Read the article on pubmed.ncbi.nlm.nih.gov ↗

Article · Jan 2023 · 1 min read

In brief

In brief

This multi-institutional retrospective study examines treatment outcomes for nine infants with BCOR-altered soft tissue sarcomas, including primitive myxoid mesenchymal tumor of infancy and undifferentiated round cell sarcoma. Eight of nine patients achieved no evidence of disease status using anthracycline-based chemotherapy regimens combined with radiotherapy, demonstrating improved outcomes compared to historical reports.

Written by the GCMD Library team from the article.

Joseph G. Pressey

BCOR alterations are described in ultra-rare infantile soft tissue sarcomas including primitive myxoid mesenchymal tumor of infancy and undifferentiated round cell sarcoma (URCS). Previous reports often describe dismal outcomes. Thus, we undertook a retrospective, multi-institutional study of infants with BCOR -rearranged soft tissue sarcomas. Nine patients aged 6 weeks to 15 months were identified. One tumor carried a BCOR :: CCNB3 fusion, whereas 7 tumors harbored internal tandem duplication of BCOR , including 4 cases classified as primitive myxoid mesenchymal tumor of infancy, 1 case as URCS, and 2 cases characterized by a "hybrid morphology" in our evaluation. Four patients underwent upfront surgery with residual disease that progressed locally after a median of 2.5 months. Locoregional recurrences were observed in hybrid patients, and the URCS case recurred with brain metastases. Complete radiographic responses after chemotherapy were achieved in patients treated with vincristine/doxorubicin/cyclophosphamide alternating with ifosfamide/etoposide, vincristine/doxorubicin/cyclophosphamide alternating with cyclophosphamide/etoposide (regimen I), and ifosfamide/carboplatin/etoposide. Seven patients received radiotherapy. With a median of 23.5 months off therapy, 8 patients are with no evidence of disease. In our study, observation was inadequate for the management of untreated postsurgical residual disease. Tumors demonstrated chemosensitivity with anthracycline-based regim

Statements in this article

  1. BCOR alterations are described in ultra-rare infantile soft tissue sarcomas including primitive myxoid mesenchymal tumor of infancy and undifferentiated round cell sarcoma.

    Established
  2. Nine patients aged 6 weeks to 15 months with BCOR-rearranged soft tissue sarcomas were identified in this multi-institutional retrospective study.

    Research
  3. One tumor carried a BCOR::CCNB3 fusion, whereas 7 tumors harbored internal tandem duplication of BCOR.

    Research
  4. Four patients underwent upfront surgery with residual disease that progressed locally after a median of 2.5 months.

    Research
  5. Locoregional recurrences were observed in hybrid morphology patients, and the undifferentiated round cell sarcoma case recurred with brain metastases.

    Research
  6. Complete radiographic responses after chemotherapy were achieved in patients treated with vincristine/doxorubicin/cyclophosphamide alternating with ifosfamide/etoposide.

    Research
  7. Complete radiographic responses after chemotherapy were achieved in patients treated with vincristine/doxorubicin/cyclophosphamide alternating with cyclophosphamide/etoposide (regimen I).

    Research
  8. Complete radiographic responses after chemotherapy were achieved in patients treated with ifosfamide/carboplatin/etoposide.

    Research
  9. Seven patients received radiotherapy.

    Research
  10. With a median of 23.5 months off therapy, 8 patients are with no evidence of disease.

    Research
  11. Observation was inadequate for the management of untreated postsurgical residual disease in this cohort.

    Recommendation
  12. Tumors demonstrated chemosensitivity with anthracycline-based regimens.

    Research

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →
GCMD Library — educational content from recorded physician discussions, not medical advice.